Article: Could Dermaseptin Analogue be a Competitive Inhibitor for ACE2 Towards Binding with Viral Spike Protein Causing COVID19?: Computational Investigation.
International journal of peptide research and therapeutics
2021 Volume 27, Issue 2, Page(s) 1043–1056
Abstract: Initial phase of COVID-19 infection is associated with the binding of viral spike protein S1 receptor binding domain (RBD) with the host cell surface receptor, ACE2. Peptide inhibitors typically interact with spike proteins in order to block its ... ...
Abstract | Initial phase of COVID-19 infection is associated with the binding of viral spike protein S1 receptor binding domain (RBD) with the host cell surface receptor, ACE2. Peptide inhibitors typically interact with spike proteins in order to block its interaction with ACE2, and this knowledge would promote the use of such peptides as therapeutic scaffolds. The present study examined the competitive inhibitor activity of a broad spectrum antimicrobial peptide, Dermaseptin-S4 (S4) and its analogues. Three structural S4 analogues viz., S4 (K |
---|---|
Language | English |
Publishing date | 2021-01-16 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 2192632-3 |
ISSN | 1573-3904 ; 1573-3149 |
ISSN (online) | 1573-3904 |
ISSN | 1573-3149 |
DOI | 10.1007/s10989-020-10149-w |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.